Nomika Indications/Uses

For infections caused by Rickettsia (Rocky Mountain spotted fever, Typhoid fever and Typhus group, Q Fever, Rickettsialpox, Tick Fever), Pneumonial mycoplasma (PPLO, Eaton agent), Psittacosis and Omithosis agent, Lymphogranuloma venereum and granuloma inguinal agent, Spirochaetal agent of Relapsing Fever (Borrelia recurrentis).
Gram-negative microorganisms: Haemophilus ducreyi, Pasteurella pestis and Pasteurella tularensis, Bartonella bacilliformis, Bacteroides species, Vibrio comma and Vibrio fetus, Brucella species (in conjunction with Streptomycin). Because some strains of microorganisms group showed resistancy to Tetracyclines, it is recommended culture and susceptibility tests.
Treatment of infections caused by gram-positive microorganisms when bacteriological testing indicates appropriate susceptibility to the drug.
Streptococcus species: up to 44% of Streptococcus spyrogenes strains and 74% of Streptococcus faecalis strains found to be resistant to Tetracycline drugs.
For treatment of Uncomplicated Gonococcal Urethritis in humans (men) due to Neisseria gonorrhoeae. When the Penicillin contraindicated, Tetracyclines are alternative medicines for the treatment of infections caused by Neisseria gonorrhoeae (in women), Treponema pallidum and Treponema pertennue (syphilis and yaws), Listeria monocytogenes, Clostridium species, Bacillus anthracis, Fusobacterium fusiforme (Vincent's Infection), Actinomyces species.
In acute intestinal amebiasis, Tetracyclines can be used as an adjunct to amoebicides.
In severe acne, Tetracyclines are used as additional therapy.
Minocyciine given orally is not indicated for the treatment of meningococcal infection. Although no controlled clinical efficacy are linked, the limit of clinical data showed that Minocycline given orally used for the treatment of infections caused by Mycobacterium marinum.